| http://www.w3.org/ns/prov#value | - ALACHUA, FL | Posted on October 11th, 2007 Using its novel particle formulation, the company has developed NanoGENT???, an inhaled dry-powder formulation of gentamicin, to provide early treatment for exposure to biological warfare agents, as well as TB and other respiratory infections.
|
